PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy

Approximately 500,000 new cases of head and neck squamous cell carcinoma (HNSCC) are reported annually. Radiation therapy is an important treatment for oral squamous cell carcinoma (OSCC). The survival rate of patients with HNSCC remained low (50%) in decades because of radiation therapy failure cau...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Fu-Cheng, Wang, Chih-Chun, Chen, Jian-Han, Hwang, Tzer-Zen, Yeh, Shyh-An, Su, Yu-Chieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817006/
https://www.ncbi.nlm.nih.gov/pubmed/33471836
http://dx.doi.org/10.1371/journal.pone.0245715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817006/
https://www.ncbi.nlm.nih.gov/pubmed/33471836
http://dx.doi.org/10.1371/journal.pone.0245715

Ejemplares similares